Trial intelligence / Profile preview

Low-dose mifepristone dose-comparison study in adenomyosis with dysmenorrhea

ChiCTR1800015514Phase 4Recruiting

Sponsor
Women's Hospital, School of Medicine, Zhejiang University
Start
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of mifepristone in adenomyosis (3 arms), sponsored by Women's Hospital, School of Medicine, Zhejiang University. Primary endpoints: Pain severity, Menstrual amount and 4 more. Started Jun 2015; status: recruiting.

02

Drugs

mifepristone
03

Conditions

adenomyosis

Beyond the preview

Go deeper on ChiCTR1800015514.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800015514.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call